Inflammatory, immunological disease startup launches with $169M


A new startup is spinning out of Waltham-based antibody discovery company Paragon Therapeutics to develop new approaches to treating immunological and inflammatory diseases.

Previous Square Roots opens new facility in Shepherdsville
Next Pizza franchisee opens 14th location, its first in Lenexa